Archive for March 2022

Affini-T Therapeutics has formally launched with $175 million in venture capital, one clinical-stage drug licensed from Fred Hutch and two more solid tumor-targeting drugs that should enter the clinic next year. Read More

Let’s take a look back at the past Inno Madness champions and see if they lived up the hype they generated during Inno Madness. Read More

Good morning, Boston. We could offer you another helping of Tom Holland and Zendaya, but you probably just want the five things you need to know to start your busy workday. Read More

Some of the most prominent Black developers in Boston, including Richard Taylor and Herby Duverne, have teamed with Tishman Speyer in the competition to build on a large city-owned parcel in Roxbury with a checkered development history. Their bid would feature less lab space than a competing proposal for the site, but hundreds more apartments.…

Two more pharmaceutical manufacturers have settled with the state of Rhode Island, worth a combined $107 million. Teva and Allergan were the last remaining defendants in Rhode Island’s sweeping opioid litigation. Read More

Good News Tuesday: Thirty years ago, 8-year-old Rachel Molly Markoff of Wellesley died from a brain tumor. Since her passing, Wellesley-based nonprofit Art in Giving — which was started by her parents, Eliane and Gary Markoff — has raised more than $2 million for basic childhood cancer research through the sale of fine arts. Read…

Activists scaled the roof of Raytheon’s facility in Cambridge "to call attention to the company’s weapons sales to Saudi Arabia and Israel, and their record of human rights violations, according to RAM INC. Read More

The developer has revealed changes to its multibillion-dollar “On The Dot” mixed-use development near the Andrew Square MBTA station in South Boston, including lowering the height of its buildings and adding more residential units. Read More

Nicole Eigbrett, director of community organizing for the Community Action Agency of Somerville, said the city has transformed into "a gold mine for investors." Read More